- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries
- Careers
- News & Insights
- About
- Languages
Insight 208 results
Client Alert
October 17, 2019
HHS Issues Proposed Rule to Update Anti-Kickback Statute Safe Harbors – What Does it Mean for Life Sciences Companies?
Client Alert
October 14, 2019
Health Headlines – October 14, 2019
Newsletter
October 7, 2019
Health Headlines – October 7, 2019
Client Alert
October 1, 2019
Cannabis Banking Bill Clears U.S. House of Representatives
Newsletter
September 30, 2019
Health Headlines – September 30, 2019
Client Alert
September 27, 2019
FDA Issued Draft Objective Performance Criteria For Five Device Types
Newsletter
September 23, 2019
Health Headlines – September 23, 2019
Newsletter
September 16, 2019
Health Headlines – September 16, 2019
Newsletter
September 9, 2019
Health Headlines – September 9, 2019
Newsletter
September 3, 2019
Health Headlines – September 3, 2019
Newsletter
August 26, 2019
Health Headlines – August 26, 2019
Newsletter
August 19, 2019
Health Headlines – August 19, 2019
Client Alert
August 13, 2019
Federal Circuit Continues Trend of Finding Diagnostic Inventions to Be Patent-Ineligible
Newsletter
August 12, 2019
Health Headlines – August 12, 2019
Client Alert
August 6, 2019
A Gimmick No More? HHS Moves to Authorize Prescription Drug Importation
Newsletter
August 5, 2019
Health Headlines – August 5, 2019
Newsletter
July 29, 2019
Health Headlines – July 29, 2019
Newsletter
July 22, 2019
Health Headlines – July 22, 2019
Newsletter
July 15, 2019
Health Headlines – July 15, 2019
Newsletter
July 8, 2019
Health Headlines – July 8, 2019
Article · Source: Intellectual Property & Technology Law Journal
July 1, 2019
FDA Proposes Regulatory Framework for Artificial Intelligence/Machine Learning Software as a Medical Device
Newsletter
July 1, 2019
Health Headlines – July 1, 2019
Newsletter
June 24, 2019
Health Headlines – June 24, 2019
Newsletter
June 10, 2019
Health Headlines – June 10, 2019
Newsletter
June 3, 2019
Health Headlines – June 3, 2019
Newsletter
May 28, 2019
Health Headlines – May 28, 2019
Newsletter
May 20, 2019
Health Headlines – May 20, 2019
Client Alert
May 14, 2019
CMS Issues Final Rule Requiring the Disclosure of Drug List Prices in Direct-to-Consumer Television Ads
Newsletter
May 13, 2019
Health Headlines – May 13, 2019
Newsletter
May 6, 2019
Health Headlines – May 6, 2019
Newsletter
April 29, 2019
Health Headlines – April 29, 2019
Client Alert
April 22, 2019
Congress Acts to Eliminate MDRP Misclassification
Newsletter
April 22, 2019
Health Headlines – April 22, 2019
Newsletter
April 15, 2019
Health Headlines – April 15, 2019
Client Alert
April 9, 2019
FDA Proposes Regulatory Framework for Artificial Intelligence/Machine Learning Software as a Medical Device
Client Alert
April 8, 2019
FDA Regulation of Cannabis
Newsletter
April 8, 2019
Health Headlines – April 8, 2019
Newsletter
April 1, 2019
Health Headlines – April, 1, 2019
Newsletter
March 25, 2019
Health Headlines – March 25, 2019
Newsletter
March 18, 2019
Health Headlines – March 18, 2019
Newsletter
March 11, 2019
Health Headlines – March 11, 2019
Newsletter
March 4, 2019
Health Headlines – March 4, 2019
Newsletter
February 25, 2019
Health Headlines – February 25, 2019
Client Alert
February 21, 2019
FDA’s Focus on Devices Impacting Women’s Health is Fully Underway: Breast Implant Advisory Set for March 25-26
Newsletter
February 18, 2019
Health Headlines – February 18, 2019
Newsletter
February 11, 2019
Health Headlines – February 11, 2019
Client Alert
February 4, 2019
HHS Proposes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors
Newsletter
February 4, 2019
Health Headlines – February 4, 2019
Thought Leadership
February 1, 2019
Selected Takeaways From King & Spalding’s 11th Annual Pharmaceutical University
Newsletter
January 28, 2019
Health Headlines – January 28, 2019
Newsletter
January 22, 2019
Health Headlines – January 22, 2019
Client Alert
January 22, 2019
FDA Tackles Digital Health Software Devices with New Pre-Certification Review Plan
Newsletter
January 14, 2019
Health Headlines – January 14, 2019
Thought Leadership
January 13, 2019
New King & Spalding Report Analyzes Latest Healthcare Industry Trends
Thought Leadership
January 11, 2019
Heather Banuelos Joins the Planning Committee for FDLI’s 2019 Advertising and Promotion for Medical Products Conference
Client Alert
January 9, 2019
AdvaMed Updates Code of Ethics on Interactions with U.S. Health Care Professionals
Newsletter
January 7, 2019
Health Headlines – January 7, 2019
Newsletter
December 31, 2018
Health Headlines – December 31, 2018
Client Alert
December 12, 2018
FDA Issues New Policy To Prevent Innovator Biologics Companies From Withholding Samples to Delay Biosimilar Competition
Newsletter
December 10, 2018
Health Headlines – December 10, 2018
Client Alert
December 7, 2018
FTC Comment on FDA Guidance
Newsletter
December 3, 2018
Health Headlines – December 3, 2018
Client Alert
December 3, 2018
FDA Announces “Modernization” Reforms to Medical Device Review Process
Newsletter
November 26, 2018
Health Headlines – November 26, 2018
Newsletter
November 19, 2018
Health Headlines – November 19, 2018
Newsletter
November 12, 2018
Health Headlines – November 12, 2018
Client Alert
November 5, 2018
Medicare Part B Payment Redux
Newsletter
November 5, 2018
Health Headlines – November 5, 2018
Article · Source: Washington Legal Foundation
November 2, 2018
Utah Court Should Find Medical Devices Merit Exception to Strict Product Liability
Newsletter
October 29, 2018
Health Headlines – October 29, 2018
Newsletter
October 22, 2018
Health Headlines – October 22, 2018
Newsletter
October 15, 2018
Health Headlines – October 15, 2018
Newsletter
October 8, 2018
Health Headlines – October 8, 2018
Newsletter
October 1, 2018
Health Headlines – October 1, 2018
Article · Source: American Bar Association Business Law Today
September 26, 2018
Cleanup on Title 5: Executive Agencies and Courts Begin to Unpack Lucia, as Litigants Eye Challenges to the Administrative State
Newsletter
September 24, 2018
Health Headlines – September 24, 2018
Newsletter
September 17, 2018
Health Headlines – September 17, 2018
Newsletter
September 10, 2018
Health Headlines – September 10, 2018
Newsletter
August 27, 2018
Health Headlines – August 27, 2018
Newsletter
August 20, 2018
Health Headlines – August 20, 2018
Client Alert
August 17, 2018
FDA Releases Draft Guidance on Agency Decisions Not to Issue Certificates to Foreign Governments
Newsletter
August 13, 2018
Health Headlines – August 13, 2018
Newsletter
August 6, 2018
Health Headlines – August 6, 2018
Newsletter
July 30, 2018
Health Headlines – July 30, 2018
Newsletter
July 23, 2018
Health Headlines – July 23, 2018
Newsletter
July 16, 2018
Health Headlines – July 16, 2018
Newsletter
July 9, 2018
Health Headlines – July 9, 2018
Newsletter
July 2, 2018
Health Headlines – July 2, 2018
Newsletter
June 25, 2018
Health Headlines – June 25, 2018
Client Alert
June 25, 2018
FDA Classifies Next Generation Sequencing-Based Tumor Profiling In Vitro Diagnostic Into Class II (Special Controls)
Client Alert
June 21, 2018
FDA Finalizes Guidances for “Consistent Communications” and Payor Communications
Article · Source: Law360 (Product Liability)
June 20, 2018
Tips for Keeping FDA Advisory Action Letters Out of Court
Newsletter
June 18, 2018
Health Headlines – June 18, 2018
Newsletter
June 11, 2018
Health Headlines – June 11, 2018
Newsletter
June 4, 2018
Health Headlines – June 4, 2018
Newsletter
May 29, 2018
Health Headlines – May 29, 2018